+Clinical trials of<unk>  Phase Registration number Start Number of participants Age of participants Total Vaccine Control I IRCT20210206050259N1 8 March 2021 135 96? 39? (placebo) 18–55 years II IRCT20210206050259N2 8 June 2021 500 250 250 (placebo) 18–70 years III IRCT20210206050259N3 29 August 2021 41,128 20,564 20,564 (Sinopharm BIBP vaccine) >18 years
FAKHRAVAC
TOFI
PATH 
SCAN
OHVIRA
SCALPEL
GRAd-COV2
CURB-65